Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
This study has been completed.
Study NCT00284193   Information provided by Sheba Medical Center

First Received on January 17, 2006.   Last Updated on July 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemophilia A
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Hemorrhagic Disorders
Additional drug interventions recognized in this trial
Factor VIII
Thrombin
More general drug interventions related to this trial
Coagulants
Hematologic Agents
Hemostatics
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sheba Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services